Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001974078-23-000298
Filing Date
2023-12-28
Accepted
2023-12-28 16:10:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 7162
  Complete submission text file 0001974078-23-000298.txt   8930
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Subject) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-32157 | Film No.: 231522819
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NEKTAR THERAPEUTICS 150 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address
Elam Nevan C (Reporting) CIK: 0001314773 (see all company filings)

Type: 144